{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T21:32:12Z","timestamp":1758144732064,"version":"3.44.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.biopha.2025.118216","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T06:53:17Z","timestamp":1748933597000},"page":"118216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A high-throughput analysis of novel anti-fibrotics in human adult cardiac fibroblasts"],"prefix":"10.1016","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4237-2024","authenticated-orcid":false,"given":"Rita N.","family":"Gomes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8834-9739","authenticated-orcid":false,"given":"Maria","family":"Cardona-Timoner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa D.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f3nio","family":"Pombinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6402-4245","authenticated-orcid":false,"given":"Diana S.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118216_bib1","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global burden of cardiovascular diseases and risks, 1990-2022","volume":"82","author":"Mensah","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2025.118216_bib2","doi-asserted-by":"crossref","first-page":"L4","DOI":"10.1093\/eurheartj\/suz235","article-title":"Ageing, demographics, and heart failure","volume":"21","author":"Coats","year":"2019","journal-title":"Eur. Heart J. Suppl."},{"key":"10.1016\/j.biopha.2025.118216_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.addr.2019.05.011","article-title":"Cardiac fibrosis \u2013 a short review of causes and therapeutic strategies","volume":"146","author":"Hinderer","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.118216_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","article-title":"Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities","volume":"65","author":"Frangogiannis","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.biopha.2025.118216_bib5","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac Fibrosis: The Fibroblast Awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.118216_bib6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.addr.2021.03.021","article-title":"Cardiac fibrosis: myofibroblast-mediated pathological regulation and drug delivery strategies","volume":"173","author":"Liu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.118216_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrcardio.2012.158","article-title":"Myofibroblast-mediated mechanisms of pathological remodelling of the heart","volume":"10","author":"Weber","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2025.118216_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cardiores.2006.07.012","article-title":"TGF\u03b2, cardiac fibroblasts, and the fibrotic response","volume":"74","author":"Leask","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biopha.2025.118216_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yjmcc.2020.04.002","article-title":"A high-content, in vitro cardiac fibrosis assay for high-throughput, phenotypic identification of compounds with anti-fibrotic activity","volume":"142","author":"Palano","year":"2020","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.biopha.2025.118216_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1124\/mol.62.1.65","article-title":"SB-431542 is a potent and specific inhibitor of transforming growth factor-\u03b2 superfamily type i activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7","volume":"62","author":"Inman","year":"2002","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2025.118216_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fphar.2017.00186","article-title":"A clinical perspective of anti-fibrotic therapies for cardiovascular disease","volume":"8","author":"Fang","year":"2017","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2025.118216_bib12","first-page":"1","article-title":"Fibrotic microtissue array to predict anti-fibrosis drug efficacy","volume":"9","author":"Asmani","year":"2018","journal-title":"Nat. Commun. 2018 9:1"},{"key":"10.1016\/j.biopha.2025.118216_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.697270","article-title":"In vitro assays and imaging methods for drug discovery for cardiac fibrosis","volume":"12","author":"Palano","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2025.118216_bib14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.tig.2017.06.005","article-title":"High-throughput imaging for the discovery of cellular mechanisms of disease","volume":"33","author":"Pegoraro","year":"2017","journal-title":"Trends Genet."},{"key":"10.1016\/j.biopha.2025.118216_bib15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.trsl.2019.03.004","article-title":"Mechanisms of cardiac collagen deposition in experimental models and human disease","volume":"209","author":"Cowling","year":"2019","journal-title":"Transl. Res."},{"key":"10.1016\/j.biopha.2025.118216_bib16","doi-asserted-by":"crossref","unstructured":"Z\u00b4factor, Z.Z., Zhang, J.-H. & Oldenburg, K.R. Z-Factor Encyclopedia of Cancer 3227\u20133228 (2008) doi:10.1007\/978-3-540-47648-1_6298.","DOI":"10.1007\/978-3-540-47648-1_6298"},{"key":"10.1016\/j.biopha.2025.118216_bib17","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1177\/2472555220942764","article-title":"Z\u2019 does not need to Be >\u20090.5","volume":"25","author":"Bar","year":"2020","journal-title":"SLAS Discov."},{"key":"10.1016\/j.biopha.2025.118216_bib18","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","article-title":"STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data","volume":"44","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2025.118216_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbadis.2016.11.006","article-title":"The role of \u03b1-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling","volume":"1863","author":"Shinde","year":"2017","journal-title":"Biochim. Et. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2025.118216_bib20","first-page":"1","article-title":"A deep learning approach to identify and segment alpha-smooth muscle actin stress fiber positive cells","volume":"11","author":"Hillsley","year":"2021","journal-title":"Sci. Rep. 2021 11:1"},{"key":"10.1016\/j.biopha.2025.118216_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123987","article-title":"High-throughput screening discovers antifibrotic properties of haloperidol by hindering myofibroblast activation","volume":"4","author":"Rehman","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2025.118216_bib22","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1016\/j.cell.2024.09.034","article-title":"Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target","volume":"187","author":"Zhang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118216_bib23","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCRESAHA.119.315491","article-title":"Generation of quiescent cardiac fibroblasts from human induced pluripotent stem cells for in vitro modeling of cardiac fibrosis","volume":"125","author":"Zhang","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.118216_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1087057105285610","article-title":"A comparison of assay performance measures in screening assays: signal window, Z\u2032 Factor, and assay variability ratio","volume":"11","author":"Iversen","year":"2006","journal-title":"SLAS Discov."},{"key":"10.1016\/j.biopha.2025.118216_bib25","article-title":"Engineered 3D cardiac fibrotic tissue to study fibrotic remodeling","volume":"6","author":"Hossein Sadeghi","year":"2017","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.biopha.2025.118216_bib26","first-page":"422","article-title":"Characterization and standardization of cultured cardiac fibroblasts for ex vivo models of heart fibrosis and heart ischemia","volume":"23","author":"Zhou","year":"2017"},{"key":"10.1016\/j.biopha.2025.118216_bib27","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1083\/jcb.142.3.873","article-title":"The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1","volume":"142","author":"Serini","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118216_bib28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jmgm.2004.08.001","article-title":"A possible model of benzimidazole binding to beta-tubulin disclosed by invoking an inter-domain movement","volume":"23","author":"Robinson","year":"2004","journal-title":"J. Mol. Graph Model"},{"key":"10.1016\/j.biopha.2025.118216_bib29","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.3390\/cancers14194601","article-title":"Repurposing of benzimidazole anthelmintic drugs as cancer therapeutics","volume":"14","author":"Song","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118216_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116630","article-title":"Mebendazole targets essential proteins in glucose metabolism leading gastric cancer cells to death","volume":"475","author":"da Silva","year":"2023","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.biopha.2025.118216_bib31","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.18632\/oncotarget.28014","article-title":"Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer","volume":"12","author":"Williamson","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118216_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0006-2952(96)00207-9","article-title":"Effects of mebendazole on protein biosynthesis and secretion in human-derived fibroblast cultures","volume":"52","author":"Soto-Trejo","year":"1996","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.biopha.2025.118216_bib33","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1186\/s12967-024-05655-0","article-title":"Albendazole ameliorates aerobic glycolysis in myofibroblasts to reverse pulmonary fibrosis","volume":"22","author":"Zeng","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2025.118216_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110384","article-title":"Colchicine prevents atrial fibrillation promotion by inhibiting IL-1\u03b2-induced IL-6 release and atrial fibrosis in the rat sterile pericarditis model","volume":"129","author":"Wu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118216_bib35","doi-asserted-by":"crossref","first-page":"15466","DOI":"10.1074\/jbc.M113.464461","article-title":"Control of myofibroblast differentiation by microtubule dynamics through a regulated localization of mDia2","volume":"288","author":"Sandbo","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118216_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1242\/jcs.93.2.255","article-title":"Fibroblast contractility and actin organization are stimulated by microtubule inhibitors","volume":"93","author":"Danowski","year":"1989","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.biopha.2025.118216_bib37","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1021\/bi400014t","article-title":"Dissecting the paclitaxel-microtubule association: quantitative assessment of the 2\u2032-OH group","volume":"52","author":"Sharma","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2025.118216_bib38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/labinvest.2009.149","article-title":"Low-dose paclitaxel ameliorates renal fibrosis in rat UUO model by inhibition of TGF-\u03b2\/Smad activity","volume":"90","author":"Zhang","year":"2010","journal-title":"Lab. Investig."},{"key":"10.1016\/j.biopha.2025.118216_bib39","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.2147\/DDDT.S81390","article-title":"Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling","volume":"9","author":"Zhang","year":"2015","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.biopha.2025.118216_bib40","first-page":"109","article-title":"Glucocorticoids induce cardiac fibrosis via mineralocorticoid receptor in oxidative stress: contribution of elongation factor eleven-nineteen lysine-rich leukemia (ELL)","volume":"57","author":"Omori","year":"2014","journal-title":"Yonago Acta Med"},{"issue":"6","key":"10.1016\/j.biopha.2025.118216_bib41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nchembio.304","article-title":"Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin","volume":"6:3","author":"Schneider-Poetsch","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2025.118216_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010522","article-title":"Inhibition of hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) protein synthesis by DNA damage inducing agents","volume":"5","author":"Lou","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118216_bib43","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3389\/fphar.2017.00326","article-title":"Targeting hypoxia inducible factors-1\u03b1 as a novel therapy in fibrosis","volume":"8","author":"Xiong","year":"2017","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118216_bib44","first-page":"935","article-title":"Cycloheximide prevents apoptosis, reactive oxygen species production, and glutathione depletion induced by transforming growth factor \u03b2 in fetal rat hepatocytes in primary culture","volume":"26","author":"Sanchez","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2025.118216_bib45","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/ar321","article-title":"The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis","volume":"3","author":"Czuwara-Ladykowska","year":"2001","journal-title":"Arthritis Res."},{"key":"10.1016\/j.biopha.2025.118216_bib46","article-title":"Intravitreal topotecan injection-induced conjunctival fibrosis mimicking extraocular extension of retinoblastoma: a rare complication","author":"Vempuluru","year":"2024","journal-title":"J. AAPOS ("},{"key":"10.1016\/j.biopha.2025.118216_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.lungcan.2006.07.017","article-title":"Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancer","volume":"54","author":"Maitland","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.biopha.2025.118216_bib48","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1476-5381.2012.01847.x","article-title":"cAMP and Epac in the regulation of tissue fibrosis","volume":"166","author":"Insel","year":"2012","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118216_bib49","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/mol.113.087742","article-title":"Increase in cellular cyclic AMP concentrations reverses the profibrogenic phenotype of cardiac myofibroblasts: a novel therapeutic approach for cardiac fibrosis","volume":"84","author":"Lu","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2025.118216_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-017-0523-z","article-title":"Dibutyryl-cAMP attenuates pulmonary fibrosis by blocking myofibroblast differentiation via PKA\/CREB\/CBP signaling in rats with silicosis","volume":"18","author":"Liu","year":"2017","journal-title":"Respir. Res."},{"key":"10.1016\/j.biopha.2025.118216_bib51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.lfs.2017.10.034","article-title":"Sustained \u03b2-AR stimulation induces synthesis and secretion of growth factors in cardiac myocytes that affect on cardiac fibroblast activation","volume":"193","author":"Nuamnaichati","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2025.118216_bib52","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/FJC.0000000000001571","article-title":"Propranolol alleviates cardiac injury after acute catecholamine infusion through p38-MAPK pathways","volume":"84","author":"Liu","year":"2024","journal-title":"J. Cardiovasc. Pharm."},{"key":"10.1016\/j.biopha.2025.118216_bib53","doi-asserted-by":"crossref","first-page":"38592","DOI":"10.1074\/jbc.M607581200","article-title":"Actin filaments are required for fibripositor-mediated collagen fibril alignment in tendon","volume":"281","author":"Canty","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118216_bib54","doi-asserted-by":"crossref","first-page":"14088","DOI":"10.3390\/ijms232214088","article-title":"Fenbendazole attenuates bleomycin-induced pulmonary fibrosis in mice via suppression of fibroblast-to-myofibroblast differentiation","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2025.118216_bib55","first-page":"1","article-title":"Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways","volume":"8:1","author":"Dogra","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500410X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500410X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:55:44Z","timestamp":1758124544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222500410X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":55,"alternative-id":["S075333222500410X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118216","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A high-throughput analysis of novel anti-fibrotics in human adult cardiac fibroblasts","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118216"}}